drugset / Trial / NCT00857116

Deworming Against Tuberculosis

NCT00857116

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The purpose of this study is to investigate whether treatment against intestinal helminths in patients with pulmonary tuberculosis undergoing chemotherapy could improve the clinical outcome by enhancing host immunity.

Timeline

Start
2009-03
Primary completion
2013-06
Completion
2013-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Albendazole Small molecule 400 mg Oral

Indications